Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Hogan

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Cancers|April 26, 2019
Dysregulation of Natural Killer Cells in ObesityDonal O'Shea, Andrew E Hogan
Nature Immunology|September 24, 2021
The IRX(3)some factor in macrophagesPaul N Moynagh, Andrew E Hogan
Frontiers in Immunology|February 6, 2023
MAITabolism<sup>2</sup> - the emerging understanding of MAIT cell metabolism and their role in metabolic diseaseNidhi Kedia-Mehta, Andrew E Hogan
Clinical Immunology (Orlando, Fla.)|August 21, 2023
NK cells vs. obesity: A tale of dysfunction & redemptionConor De Barra, Donal O'Shea, Andrew E Hogan
Trends in Endocrinology and Metabolism: TEM|January 10, 2015
Lymphocyte roles in metabolic dysfunction: of men and miceBlanche C Ip, Andrew E Hogan, Barbara S Nikolajczyk
Science Signaling|June 2, 2026
Environmental regulation of mucosal-associated invariant T cells: Adding food for thoughtEimear K Ryan, Linda V Sinclair, Andrew E Hogan
Frontiers in Immunology|July 18, 2022
Obesity-Mediated Immune Modulation: One Step Forward, (Th)2 Steps BackViviane Schmidt, Andrew E Hogan, Padraic G Fallon, et al.
Cancers|April 3, 2021
Mucosal Associated Invariant T Cells in Cancer-Friend or Foe?Chloe O'Neill, Féaron C Cassidy, Donal O'Shea, et al.
European Journal of Immunology|July 4, 2020
Interleukin-17 producing mucosal associated invariant T cells - emerging players in chronic inflammatory diseases?Marta M Pisarska, Margaret R Dunne, Donal O'Shea, et al.
Trends in Endocrinology and Metabolism: TEM|August 14, 2025
Repurposing metabolic drugs as anti-inflammatory agentsAndrew E Hogan, Cian Davis, Benjamin J Jenkins, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Cancers|April 26, 2019
Dysregulation of Natural Killer Cells in ObesityDonal O'Shea, Andrew E Hogan
Nature Immunology|September 24, 2021
The IRX(3)some factor in macrophagesPaul N Moynagh, Andrew E Hogan
Frontiers in Immunology|February 6, 2023
MAITabolism<sup>2</sup> - the emerging understanding of MAIT cell metabolism and their role in metabolic diseaseNidhi Kedia-Mehta, Andrew E Hogan
Clinical Immunology (Orlando, Fla.)|August 21, 2023
NK cells vs. obesity: A tale of dysfunction & redemptionConor De Barra, Donal O'Shea, Andrew E Hogan
Trends in Endocrinology and Metabolism: TEM|January 10, 2015
Lymphocyte roles in metabolic dysfunction: of men and miceBlanche C Ip, Andrew E Hogan, Barbara S Nikolajczyk
Science Signaling|June 2, 2026
Environmental regulation of mucosal-associated invariant T cells: Adding food for thoughtEimear K Ryan, Linda V Sinclair, Andrew E Hogan
Frontiers in Immunology|July 18, 2022
Obesity-Mediated Immune Modulation: One Step Forward, (Th)2 Steps BackViviane Schmidt, Andrew E Hogan, Padraic G Fallon, et al.
Cancers|April 3, 2021
Mucosal Associated Invariant T Cells in Cancer-Friend or Foe?Chloe O'Neill, Féaron C Cassidy, Donal O'Shea, et al.
European Journal of Immunology|July 4, 2020
Interleukin-17 producing mucosal associated invariant T cells - emerging players in chronic inflammatory diseases?Marta M Pisarska, Margaret R Dunne, Donal O'Shea, et al.
Trends in Endocrinology and Metabolism: TEM|August 14, 2025
Repurposing metabolic drugs as anti-inflammatory agentsAndrew E Hogan, Cian Davis, Benjamin J Jenkins, et al.
Pageof 7